Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. [electronic resource]
Producer: 20201103Description: 196-200 p. digitalISSN:- 2168-6084
- Adolescent
- Brazil
- Child
- Child, Preschool
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- administration & dosage
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Infant
- Keratoderma, Palmoplantar -- drug therapy
- Male
- Protein Kinase Inhibitors -- administration & dosage
- Signal Transduction -- drug effects
- Sirolimus -- administration & dosage
- Syndrome
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.